Action on sickle cell retinopathy: the time is now
- PMID: 35087214
- PMCID: PMC9151806
- DOI: 10.1038/s41433-021-01918-y
Action on sickle cell retinopathy: the time is now
Conflict of interest statement
The authors declare no competing interests.
Comment in
-
Screening for sickle-cell retinopathy.Eye (Lond). 2023 Feb;37(2):375. doi: 10.1038/s41433-022-02199-9. Epub 2022 Aug 26. Eye (Lond). 2023. PMID: 36028761 Free PMC article. No abstract available.
References
-
- National Institute of Health and Care Excellence Technology appraisal guidance (TA743). Crizanlizumab for preventing sickle cell crises in sickle cell disease. 2021. https://www.nice.org.uk/guidance/ta743. Accessed 08/11/2021.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
